{
    "clinical_study": {
        "@rank": "47023", 
        "arm_group": [
            {
                "arm_group_label": "pneumatic compression 1 hour per day", 
                "arm_group_type": "Experimental", 
                "description": "Pneumatic compression device - 12 consecutive days undergoing a 1 hour treatment regimen."
            }, 
            {
                "arm_group_label": "pneumatic compression - 2 hours per day", 
                "arm_group_type": "Experimental", 
                "description": "Pneumatic compression device - 5 consecutive days undergoing 1 hour treatment in the am and 1 hour of treatment in the pm."
            }, 
            {
                "arm_group_label": "pneumatic compression - 4 hours per day", 
                "arm_group_type": "Experimental", 
                "description": "Pneumatic compression device - 5 consecutive days undergoing treatment twice per day consisting of 2 consecutive 1 hour treatments in the am and the pm (4 hours total)"
            }
        ], 
        "brief_summary": {
            "textblock": "Proof of principle study in order to determine if there is a difference in treatment effect\n      across the 3 study groups when treating lower extremity lymphoedema using a pneumatic\n      compression device."
        }, 
        "brief_title": "Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Lower Extremity Lymphoedema", 
            "Leg Lymphoedema"
        ], 
        "condition_browse": {
            "mesh_term": "Lymphedema"
        }, 
        "detailed_description": {
            "textblock": "This is a single center, 3 arm, prospective, randomized, clinical trial to assess the\n      difference between 3 treatment options for achieving a measurable physiologic effect on\n      lower extremity lymphedema with pneumatic compression device. Each intervention arm will\n      include 10 completed subjects for a total of 30 completed subjects."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must be \u2265 18 years old\n\n          -  Subjects must have a diagnosis of secondary Stage 2 unilateral or bilateral lower\n             extremity lymphoedema.\n\n          -  Must currently be using adequate compression garment(s):\n\n          -  Subjects must have clinically relevant excess limb swelling as determined by\n             clinician \"pitting test\".\n\n          -  Must be able to attend all required in-clinic treatment visits\n\n        Exclusion Criteria:\n\n          -  Diagnosis of active or recurrent cancer, or less than 3 months at the time of initial\n             evaluation from the completion of chemotherapy, radiation therapy or primary surgery\n             for the treatment of cancer.\n\n          -  Active infection or inflammation\n\n          -  Active thrombophlebitis (within the last 2 months)\n\n          -  History of  pulmonary embolism (within the last 2 months)\n\n          -  Documented history of deep chronic venous insufficiency or deep venous obstruction\n             with  a reflux duration of > 2 second in the deep system, and any history of deep\n             vein thrombosis (DVT)\n\n          -  History of pulmonary edema\n\n          -  History of congestive heart failure\n\n          -  History of chronic kidney disease with a glomerular filtration rate (GFR) of less\n             than 30 mls per minute.\n\n          -  Patients with poorly controlled asthma\n\n          -  Symptomatic or severe peripheral artery disease, defined by current\n             lifestyle-limiting claudication or critical limb ischemia\n\n          -  Presence of an open wound or ulcer of any etiology\n\n          -  Diagnosis of lipoedema and lipolymphoedema*\n\n          -  Currently using an in home pneumatic compression device\n\n          -  Metal implants that would interfere with bio impedance equipment\n\n          -  Individual with pacemaker or other implanted electronic devices\n\n          -  Inability or unwillingness to remove bandaging from treatment regimen while\n             participating in the study.\n\n          -  Pregnancy\n\n          -  Any condition where increased venous and lymphatic return is undesirable\n\n          -  Inability or unwillingness to participate in all aspects of study protocol and/or\n             inability to provide informed consent\n\n          -  Currently participating in another clinical trial\n\n          -  Currently using diuretics\n\n          -  BMI > 35"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031627", 
            "org_study_id": "4010 FlexDose"
        }, 
        "intervention": [
            {
                "arm_group_label": "pneumatic compression 1 hour per day", 
                "description": "Pneumatic compression treatment once per day (1 hour)", 
                "intervention_name": "pneumatic compression 1 hour per day", 
                "intervention_type": "Device", 
                "other_name": [
                    "Flexitouch pump", 
                    "Flexitouch device"
                ]
            }, 
            {
                "arm_group_label": "pneumatic compression - 2 hours per day", 
                "description": "pneumatic compression treatment twice per day (am and pm = 2 hours)", 
                "intervention_name": "pneumatic compression - 2 hours per day", 
                "intervention_type": "Device", 
                "other_name": [
                    "Flexitouch pump", 
                    "Flexitouch device"
                ]
            }, 
            {
                "arm_group_label": "pneumatic compression - 4 hours per day", 
                "description": "pneumatic compression treatment twice per day consisting of 2 consecutive 1 hour treatments in the AM & PM (4 hours)", 
                "intervention_name": "pneumatic compression - 4 hours per day", 
                "intervention_type": "Device", 
                "other_name": [
                    "Flexitouch pump", 
                    "Flexitouch device"
                ]
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "lymphedema", 
            "lymphoedema", 
            "leg lymphoedema", 
            "lower extremity lymphoedema", 
            "pneumatic compression device"
        ], 
        "lastchanged_date": "January 17, 2014", 
        "location": {
            "contact": {
                "last_name": "Vaughan Keeley, PhD, FRCP"
            }, 
            "facility": {
                "address": {
                    "city": "Derby", 
                    "country": "United Kingdom", 
                    "zip": "DE22 3NE"
                }, 
                "name": "Royal Derby Hospital"
            }, 
            "investigator": {
                "last_name": "Vaughan Keeley, PhD, FRCP", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "3", 
        "official_title": "Physiologic Response to Varying Lymphoedema Compression Programs With the Flexitouch System", 
        "overall_contact": {
            "email": "shoy@tactilemedical.com", 
            "last_name": "Sunday Hoy"
        }, 
        "overall_official": {
            "affiliation": "Royal Derby Hospital", 
            "last_name": "Vaughan Keeley, PhD, FRCP", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: National Health Service", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The study will use bioimpedance to determine intra and extra cellular fluid changes.", 
            "measure": "Intra/extra cellular fluid changes", 
            "safety_issue": "Yes", 
            "time_frame": "Day 5 and 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031627"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Tactile Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tactile Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}